← All diseases
Muscles and connective tissue
Systemic sclerosis (scleroderma)
Do you want to receive a message when there is new research about Systemic sclerosis (scleroderma)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a summary sentence appears above each publication explaining what was studied — and you'll receive notification as soon as new research on Systemic sclerosis (scleroderma) is published. View what Premium costs.
Publications and studies (2101)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. RY_SW01 Cell Injection Therapy in Systemic Sclerosis (2024-01-18) ♡
- Analysis of Hand Function, Upper Limb Disability, and Its Relationship with Peripheral Vascular Alterations in Raynaud's Phenomenon. (2023/12/30) ♡
- Retracted: The Function of Retinal Thickness and Microvascular Alterations in the Diagnosis of Systemic Sclerosis. (2023/12/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis. (2023/12/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms. (2023/12/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Primary Central Nervous System Lymphoma That Developed in a Patient Receiving Fingolimod Therapy for Multiple Sclerosis. (2023/12/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report of systemic sclerosis: Uncommon manifestation of nephrotic syndrome post-renal crisis. (2023/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exosomal microRNA-Based therapies for skin diseases. (2023/12/23) ♡
- Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis. (2023/12/23) ♡
- SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis. (2023/12/21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients. (2023/12/21) ♡
- miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis. (2023/12/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Eosinophilic Fasciitis Presenting as Chronic Nonspecific Symptoms in a Young Adult. (2023/12/19) ♡
- Clinically Recognized Depression and Mental Health Treatment in a Single Center Cohort of Patients with Systemic Sclerosis. (2023/12/19) ♡
- Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. (2023/12/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nodular and diffuse spindle cell infiltration in keloidal scleroderma: a case report. (2023/12/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. (2023/12/16) ♡
- Synthetic Nucleic Acid Antigens in Localized Scleroderma. (2023/12/15) ♡
- Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study. (2023/12/14) ♡
- Mitochondrial DNA copy number in patients with systemic sclerosis. (2023/12/14) ♡
- Loss of Endothelial TDP-43 Leads to Blood Brain Barrier Defects in Mouse Models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. (2023/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases. (2023/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interorgan communication with the liver: novel mechanisms and therapeutic targets. (2023/12/12) ♡
- Distal periarterial sympathectomy surgery for chronic digital ischemia: A systematic review of the literature. (2023/12/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. [Early recognition and prevention of systemic sclerosis]. (2023/12/06) ♡
- A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome. (2023/12/05) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial. (2023/12/01) ♡
- High prevalence of malnutrition in systemic sclerosis: Results from a French monocentric cross-sectional study. (2023/12/01) ♡
- Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. (2023/12/01) ♡
- Anti-Inflammatory Effects of Chaenomeles sinensis Extract in an ALS Animal Model. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ponesimod-Associated Macular Edema: Onset and Resolution. (2023/12/01) ♡
- Mitochondrial DNA Sensing Pathogen Recognition Receptors in Systemic Sclerosis Associated Interstitial Lung Disease: A Review. (2023/12/01) ♡
- Erratum to: Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis. (2023/12/01) ♡
- TANGO1 Dances to Export of Procollagen from the Endoplasmic Reticulum. (2023/12/01) ♡
- Systemic sclerosis associated myopathy: how to treat. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Improvement of systemic sclerosis-associated digital ulcers after ultraviolet A1 phototherapy. (2023/11/30) ♡
- Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study. (2023/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Eculizumab Use in Scleroderma Renal Crisis With Thrombotic Microangiopathy: A Case Report. (2023/11/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Delayed Extubation of a Patient With Multiple Sclerosis. (2023/11/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy, tolerance and acceptability of pulsed dye laser on facial and neckline telangiectasias in systemic scleroderma: a prospective open-label monocentric study in 21 patients. (2023/11/17) ♡
- Liposomal aggregates sustain the release of rapamycin and protect cartilage from friction. (2023/11/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mixed connective tissue and ovarian cancer: a case report. (2023/11/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel perspectives on leptin in osteoarthritis: Focus on aging. (2023/11/04) ♡
- Epicardial adipose tissue in patients with systemic sclerosis. (2023/11/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D: immune function, inflammation, infections and auto-immunity. (2023/11/01) ♡
- GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis: A retrospective study. (2023/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases? (2023/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside. (2023/11/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial. (2023/11/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.